MPower Partners Fund, Japan’s first ESG-focused global venture capital fund, has invested in TXP Medical (Tokyo, Japan), a company that enhances healthcare efficiency and quality through digital transformation and medical data.

In the field of emergency medicine, the complexity of information management and decision-making, the burden of manual tasks required during urgent treatment, and the resulting strain on healthcare professionals have been longstanding challenges. Additionally, fragmented medical data and delays in its utilization negatively impact the quality and speed of care, making it crucial to address these issues promptly in life-critical situations.

TXP Medical, through its acute care-focused medical data platform "NEXT Stage Series," has achieved data collection and operational efficiency in 79 major hospitals nationwide, covering approximately 40% of university hospitals and emergency centers. For emergency response teams, the company has implemented "NSER Mobile" across 42 regions, enabling digital record-keeping and rapid patient information documentation using voice and image analysis, covering a population of over 10 million. TXP Medical has also developed a specialized medical database for rare cancers, rare diseases, and severe illnesses, contributing to innovations and advancements in R&D through collaborations with pharmaceutical companies.

The driving force behind TXP Medical's remarkable growth is a team of highly skilled and mission-driven individuals with extensive experience in the medical field. Led by CEO Dr. Tomohiro Sonoo, the team includes medical professionals and former healthcare workers with deep expertise and on-the-ground knowledge, who have launched multiple products to support the next generation of healthcare.

MPower Partners has been deeply inspired by TXP Medical's commitment to "Clinically good, socially good" as it leads the transformation of healthcare by engaging various stakeholders such as hospitals and municipalities. We are fully committed to supporting the company as it scales its business through strategies involving technologies like generative AI and implements ESG practices for both internal and external stakeholders. Through this partnership, we aim to help TXP Medical continue to drive change in the healthcare field and contribute to a more sustainable society.

Comment from Dr. Tomohiro Sonoo, CEO

TXP Medical is a startup with a mission to "Save lives with medical data." The company offers a wide range of services, from building platforms for acute care to utilizing medical data. TXP Medical provides the "NEXT Stage Series," a medical data platform for acute care hospitals and municipalities, clinical research support for academia, and real-world data (RWD) utilization and analysis services for pharmaceutical companies. The company is actively involved in numerous projects, including the Cabinet Office's SIP (Phase 3) supplementary budget initiative, "Utilization of Generative AI in Building Integrated Healthcare Systems," and the Ministry of Health, Labour and Welfare's "Project for Promoting Innovation in Small and Medium-sized Enterprises: Development and Demonstration of AI Technologies Tailored to Medical Needs for Implementing AI Hospitals." TXP Medical is a leader in Japan's medical research and development.

The philosophy of MPower Partners, which emphasizes "sustainable growth from an ESG perspective" and "addressing societal challenges through technology," is a crucial pillar for supporting the future of healthcare. TXP Medical's team is committed to fulfilling our mission of improving the quality of healthcare in Japan, particularly in a time when workstyle reforms are being demanded in the medical field.

With this round of funding, we will not only expand our existing businesses but also develop and deploy generative AI-based services for medical settings, further solidifying our presence as essential infrastructure in Japan's healthcare system. To realize our vision and drive business growth, we will focus on strengthening our management structure and actively recruiting and nurturing talent.

About TXP Medical

• CEO: Tomohiro Sonoo (Emergency and Critical Care Physician)

• Established: August 28, 2017

• Number of Employees: 78 (as of October 2024)

• Location: 1010042 41-1 Kanda Higashimatsushita-cho, Chiyoda-ku, Tokyo, H¹O Kanda 706

• Corporate URL: https://txpmedical.jp/

About MPower Partners

MPower Partners Fund is Japan’s first ESG-integrated global venture capital fund that aims to support entrepreneurs providing solutions to societal challenges through the power of technology, and to promote sustainable growth by incorporating ESG (Environment, Social, Governance) into their core business strategies. The founding team draws on their extensive experience in the financial industry and ESG matters to support the global expansion of startups and strives to infuse ESG elements into the ecosystem. 

Fund website: https://www.mpower-partners.com

For inquiries, please contact: info@mpower-partners.com

This press release has been prepared for the purpose of providing information to qualified institutional investors and potential portfolio companies of the Fund, and is not a disclosure document pursuant to the Financial Instruments and Exchange Act, and does not constitute a solicitation or recommendation to purchase the Fund.